DiscoverThe CheckRare Brief
The CheckRare Brief
Claim Ownership

The CheckRare Brief

Author: CheckRare

Subscribed: 0Played: 0
Share

Description

A weekly roundup of the latest news in rare disease.

The CheckRare Brief delivers a concise roundup of the week's most important developments in rare diseases. Each episode covers FDA approvals, clinical trial updates, conference highlights, scientific publications, and industry news that matter to healthcare professionals, researchers, advocates, and the rare disease community.

Produced by CheckRare, The CheckRare Brief helps you stay informed—in just a few minutes each week.

16 Episodes
Reverse
On this special edition of the CheckRare Brief, we talk with Alaa Hamed, Sanofi's Global Head of Medical Affairs for Rare Diseases, and Maite Durrenbach, Head of Specialty Care and Supply at Sanofi, about the company’s current supply chain problems for some of their biological therapies.Back in August, the CheckRare Brief covered the drug supply disruptions affecting patients receiving Sanofi's enzyme replacement therapies. The problems centered around Sanofi's Waterford, Ireland, manufacturing facility. The FDA had inspected the site in January and issued a warning letter in June citing deficiencies in its quality systems.In the months that followed, patients in several countries experienced delays in accessing treatments for rare diseases, including Pompe, Fabry, and Gaucher.Since then, Sanofi has issued additional supply updates that may disrupt supply for some of those therapies into 2027 while a new manufacturing site get build. In addition, the company recently disclosed a potential longer-term supply shortfall for Xenpozyme, its treatment for ASMD.Topics covered in this conversation includeOngoing supply challengesThe anticipated Xenpozyme shortfall from mid-2027Protecting access to therapies for the most vulnerablePreventing future disruptionsProduced by CheckRare.Explore additional CME activities, physician interviews, podcasts, and rare disease resources at CheckRare.com. Subscribe to the CheckRare Podcast Network for the latest rare disease education, expert interviews, and weekly news.Part of the CheckRare Podcast Network: Trusted conversations, news, education, and expert insights across the rare disease community.
In this episode, we discuss highlights from The Liver Meeting, Ultragenyx program cuts, and ANI Pharmaceuticals’ offer to buy Egetis Therapeutics.Produced by CheckRare.Explore additional CME activities, physician interviews, podcasts, and rare disease resources at CheckRare.com. Subscribe to the CheckRare Podcast Network for the latest rare disease education, expert interviews, and weekly news.Part of the CheckRare Podcast Network: Trusted conversations, news, education, and expert insights across the rare disease community.
In this episode, we discuss a new formulation of treatment for HAE, the FDA approval of Voceryq for recurrent respiratory papillomatosis, and 3D printed treatment options.Produced by CheckRare.Explore additional CME activities, physician interviews, podcasts, and rare disease resources at CheckRare.com. Subscribe to the CheckRare Podcast Network for the latest rare disease education, expert interviews, and weekly news.Part of the CheckRare Podcast Network: Trusted conversations, news, education, and expert insights across the rare disease community.
In this episode, we discuss gambling on clinical trials, the FDA approval of a new formulation of Sjögren’s disease treatment, and an approval in IgA nephropathy.Produced by CheckRare.Explore additional CME activities, physician interviews, podcasts, and rare disease resources at CheckRare.com. Subscribe to the CheckRare Podcast Network for the latest rare disease education, expert interviews, and weekly news.Part of the CheckRare Podcast Network: Trusted conversations, news, education, and expert insights across the rare disease community.
On this episode, we discuss the FDA approval of Enspryng for TED, the new FDA Rare Disease Framework Initiative, Ultrangenyx’s second sold PRV this month, and using AI to reduce diagnostic delays.Produced by CheckRare.Explore additional CME activities, physician interviews, podcasts, and rare disease resources at CheckRare.com. Subscribe to the CheckRare Podcast Network for the latest rare disease education, expert interviews, and weekly news.Part of the CheckRare Podcast Network: Trusted conversations, news, education, and expert insights across the rare disease community.
loading
Comments